The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Evaluation of intra-tumoral (IT) SD-101 and pembrolizumab (Pb) in combination with paclitaxel (P) followed by AC in high-risk HER2-negative (HER2-) stage II/III breast cancer: Results from the I-SPY 2 trial.
 
Amy Jo Chien
Research Funding - Amgen (Inst); Astellas Pharma (Inst); Merck (Inst); Puma Biotechnology (Inst); Seagen (Inst)
 
Hatem Hussein Soliman
Consulting or Advisory Role - AstraZeneca; Celgene; Eisai; Immunomedics; Novartis; Puma Biotechnology; Seagen
Speakers' Bureau - Sanofi
Research Funding - Amgen (Inst)
Patents, Royalties, Other Intellectual Property - Celeyad licensing agreement (Inst)
 
Cheryl Ann Ewing
No Relationships to Disclose
 
Judy Caroline Boughey
Honoraria - UpToDate
Consulting or Advisory Role - CairnSurgical
Research Funding - Lilly (Inst)
Patents, Royalties, Other Intellectual Property - Patent pending - METHODS AND MATERIALS FOR ASSESSING CHEMOTHERAPY RESPONSIVENESS AND TREATING CANCER (Inst)
 
Michael J. Campbell
No Relationships to Disclose
 
Hope S. Rugo
Honoraria - Mylan; Puma Biotechnology
Consulting or Advisory Role - Samsung
Research Funding - AstraZeneca (Inst); Daiichi Sankyo (Inst); Eisai (Inst); Genentech (Inst); Immunomedics (Inst); Lilly (Inst); Macrogenics (Inst); Merck (Inst); Novartis (Inst); OBI Pharma (Inst); Odonate Therapeutics (Inst); Pfizer (Inst); Seagen (Inst); Sermonix Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - AstraZeneca Spain; Daiichi Sankyo; Macrogenics; Merck; Mylan; Novartis; Pfizer
 
Anne M. Wallace
No Relationships to Disclose
 
Kathy S. Albain
Consulting or Advisory Role - Agendia; Genentech/Roche; Genomic Health; Myriad Genetics; Novartis; Pfizer
Research Funding - Seagen; Seagen (Inst)
Other Relationship - Puma Biotechnology
 
Erica Michelle Stringer-Reasor
Honoraria - Breast Cancer Index; Lilly; Mylan
Consulting or Advisory Role - Immunomedics; Lilly; Novartis
Speakers' Bureau - Lilly
Research Funding - Susan G. Komen for the Cure; V Foundation
Travel, Accommodations, Expenses - Cascadian Therapeutics; Lilly
(OPTIONAL) Uncompensated Relationships - Genentech
 
An L Church
No Relationships to Disclose
 
Kevin Kalinsky
Stock and Other Ownership Interests - Array BioPharma (I); GRAIL (I); Pfizer (I)
Consulting or Advisory Role - AstraZeneca; bioTheranostics; Cyclacel; Eisai; Genentech/Roche; immunomedics; Ipsen; Lilly; Merck; Novartis; Oncosec; pfizer; Seagen
Speakers' Bureau - Lilly
Research Funding - Acetylon Pharmaceuticals (Inst); Amgen (Inst); Calithera Biosciences (Inst); CytomX Therapeutics (Inst); Genentech/Roche (Inst); Immunomedics (Inst); incyte (Inst); Lilly (Inst); Novartis (Inst); Pfizer (Inst); Seagen (Inst); Zeno Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Lilly; Pfizer
Other Relationship - Genentech; Immunomedics
 
Anthony D. Elias
Stock and Other Ownership Interests - Abbott Laboratories; Abbvie; Agilent; Alexion Pharmaceuticals; Align Oncology; Allergan; Amgen; Biogenerix; Bristol-Myers Squibb; Cigna; Exact Sciences; Gilead Sciences; Illumina; Lilly; Merck; Pfizer; United Health Group
Consulting or Advisory Role - Ayala Pharmaceuticals
Research Funding - Astellas Pharma (Inst); BioAtla (Inst); Deciphera (Inst); Genentech (Inst); Infinity Pharmaceuticals (Inst); Karyopharm Therapeutics (Inst); Medivation (Inst); Orinove (Inst); TopAlliance BioSciences Inc (Inst); xencor (Inst)
(OPTIONAL) Uncompensated Relationships - Seiyax
 
Zahi Ibrahim Mitri
Consulting or Advisory Role - Lilly
Research Funding - AstraZeneca (Inst); Daiichi Sankyo (Inst); Novartis (Inst); Radius Health (Inst); Seagen (Inst)
 
Amy Sanders Clark
Consulting or Advisory Role - Novartis
Research Funding - Novartis (Inst); Seagen
 
Rita Nanda
Consulting or Advisory Role - Aduro Biotech; Athenex; Daiichi Sankyo; Genentech/Roche; Immunomedics; ION Pharma; Macrogenics; Merck; Pfizer; Seagen
Research Funding - Abbvie (Inst); AstraZeneca (Inst); Celgene (Inst); Corcept Therapeutics (Inst); Genentech/Roche (Inst); Immunomedics (Inst); Merck (Inst); Odonate Therapeutics (Inst); Pfizer (Inst); Seagen (Inst)
Other Relationship - G1 Therapeutics
 
Alexandra Thomas
Stock and Other Ownership Interests - Bristol-Myers Squibb; Gilead Sciences; Johnson & Johnson (I); Pfizer
Consulting or Advisory Role - BeyondSpring Pharmaceuticals
Research Funding - Sanofi (Inst)
Patents, Royalties, Other Intellectual Property - Up-to-Date Royalties (I)
Travel, Accommodations, Expenses - Genentech
 
Christina Yau
No Relationships to Disclose
 
I-SPY 2 Consortium
No Relationships to Disclose
 
Donald A Berry
No Relationships to Disclose
 
Laura Esserman
Consulting or Advisory Role - Blue Cross Blue Shield Association
Research Funding - Merck
Travel, Accommodations, Expenses - Blue Cross Blue Shield Association
(OPTIONAL) Uncompensated Relationships - Quantum Leap Healthcare Collaborative